Catabasis Pharmaceuticals Inc (CATB) is around the top of the Healthcare sector according to InvestorsObserver.
CATB received an overall rating of 68, which means that it scores higher than 68% of stocks. Additionally, Catabasis Pharmaceuticals Inc scored a 75 in the Healthcare sector, ranking it higher than 75% of stocks in that sector.
What do These Ratings Mean?
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 68 would rank higher than 68 percent of all stocks.
Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score.
The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With Catabasis Pharmaceuticals Inc Stock Today?
Catabasis Pharmaceuticals Inc (CATB) stock is trading at $5.98 as of 3:05 PM on Friday, Sep 4, a drop of -$0.10, or -1.64% from the previous closing price of $6.08. The stock has traded between $5.55 and $6.20 so far today. Volume today is 409,098 compared to average volume of 371,024.
Click Here to get the full Stock Score Report on Catabasis Pharmaceuticals Inc (CATB) Stock.
